Clinico-pathological study of craniopharyngioma

Authors

  • Mohammed Sikandar Department of Neurosurgery, M. G. M. Hospital, Kakatiya Medical College, Warangal, Telangana, India
  • G. Venugopal Department of Neurosurgery, M. G. M. Hospital, Kakatiya Medical College, Warangal, Telangana, India
  • M. Srinivas Reddy Department of Neurosurgery, Sri Krishna Hospital, Mahbubnagar, Telangana, India

DOI:

https://doi.org/10.18203/2349-2902.isj20220624

Keywords:

Craniopharyngiomas, Hydrocephalus, Endocrinological abnormalities, Pterional approach

Abstract

Background: Craniopharyngioma is a tumour of the suprasellar region that histologically has two distinct variants with some differences in clinical behaviour. The papillary type is almost always seen in adults and has a more indolent course. We studied clinical and radiological characteristics, surgical resectability, clinical outcome and recurrence patterns in tertiary care center.

Methods: The present study is a prospective study, comprising of 32 patients of craniopharyngiomas studies over a period of 3 years. All the patients were thoroughly evaluated for the symptoms and signs with particular stress on visual impairment and field defects.

Results: There were 16 male and 16 female patients. The incidence of craniopharyngioma was observed more in the age group of 6-10 years. Fundoscopy examination revealed optic atrophy and papilloedema in (56.25%) eases. Endocrinological dysfunction were present in 31.25% cases. Appearance on computed tomography (CT) scan showed 31.25% as cystic and 68.75% was mixed respectively. Surgical approach to the tumor was through pterional approach in (75%) sub frontal in (18.75%) transphenoidal in 18.75%. There was 2 death, 10 patients were advised postoperative radiotherapy and follow up period was from 6 months to 2 years. There were 6 recurrences out of 32 patients who were under follow-up.

Conclusions: Treatment should focus not only on long term control and survival, but also on the reduction of the disease and related morbidity and preservation of quality of life.

References

Rutka JT. Craniopharyngioma-editorial note: J Neurosurg. 2002;97(1):1-2.

Hindman NM, Hecht EM, Bosniak MA. Follow-up for Bosniak Category 2F Cystic Renal Lesions: Radiology. 2014;272(3):757-66.

Schoenfeld A, Pekmezci M, Barnes MJ. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol. 2012;108:133-9.

Sughrue ME, Yang I, Kane AJ. Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol. 2011;101:463-76.

Nielsen EH, Feldt-Rasmussen U, Poulsgaard L, Kristensen LO, Astrup J, Jørgensen JO, et al. Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults. J Neurooncol. 2011;104:755-63.

Pant I, Chaturvedi S. Diagnostic approach to histopathology of central nervous system papillary tumors. Astrocyte. 2014;1:124-31.

Karavitaki N, Cudlip S, Adams CB, Wass JA. Craniopharyngiomas. Endocr Rev. 2006;27:371-97.

Petito CK, DeGirolami U, Earle KM. Craniopharyngiomas: A clinical and pathological review. Cancer. 1976;37:1944-52.

Fatemi N, Dusick JR, de Paiva Neto MA, Malkasian D, Kelly DF. Endonasal versus supraorbital keyhole removal of craniopharyngiomas and tuberculum sellae meningiomas. Neurosurgery. 2009;64(5):269-84.

Dhandapani S, Singh H, Negm HM. Endonasal endoscopic reoperation for residual or recurrent craniopharyngiomas. J Neurosurg. 2017;126:418-30.

Tariq MU, Din NU, Ahmad Z, Memon W. Papillary craniopharyngioma: A clinicopathologic study of a rare entity from a major tertiary care center in Pakistan. Neurol India. 2017;65:570-6.

Shin JL, Asa SL, Woodhouse LJ, Smyth HS, Ezzat S. Cystic lesions of the pituitary: Clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst. J Clin Endocrinol Metab. 1999;84:3972-82.

Yaşargil MG, Curcic M, Kis M, Siegenthaler G, Teddy PJ, Roth P. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosur. 1990:73:3-11.

Fernandez-Miranda JC, Gardner PA, Snyderman CH, Devaney KO, Strojan P, et al. Craniopharyngioma: A pathologic, clinical, and surgical review. Head Neck. 2012;34:1036-44.

Sung JJY. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2014;64:121-32.

Bartlett JR. Craniopharyngioms- a summary of 85 cases. J Neurol Neurosurg Psychiat. 1971;34:37-41.

Barua KK. Treatment of recurrent craniopharyngiomas: Kobe J Med Sci. 2003;49(6):123-32.

Nagpal RD. Craniopharyngioma: treatment by conservative surgery and radiotherpy J Postgrad Med. 1992;38(4):175-80.

Downloads

Published

2022-02-28

Issue

Section

Original Research Articles